Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CO › Loveland › NPI 1962157404
Physician

Poudre Valley Medical Group, LLC

Poudre Valley Medical Group, LLC was paid $143K by Medicaid between Feb 2022 and Dec 2024, across 7 billing codes. Its largest line is Q0222, Injection, bebtelovimab, 175 mg — 46% of everything it billed.

33Billing provider infoPOUDRE VALLEY MEDICAL GROUP, LLC
LOVELAND, CO 80538
33aNPI1962157404assigned 02/14/2022
28Total paid$143K
24GClaims610
24DCodes billed7
24AFirst – last monthFeb 2022 – Dec 2024
Compared with peers

Next to other Infectious Disease Physician providers in Colorado

Rank by total paid#8 of 12
Median peer was paid$206K
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official CONROY, JANA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2022267$121K
2023145$8K
2024incomplete198$14K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
Q0222 Injection, bebtelovimab, 175 mg 46% 32 32 $65K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring 19% 83 82 $27K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 15% 343 328 $21K
J0248 Injection, remdesivir, 1 mg 14% 42 14 $20K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 5.0% 35 30 $7K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 41 14 $2K
Q0247 Injection, sotrovimab, 500 mg <1% 34 29 $0.17

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCONROY, JANA (DIRECTOR OF CREDENTIALING)
Parent organizationPOUDRE VALLEY MEDICAL GROUP, LLC
Same official

Other billing entities under CONROY, JANA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.